GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » EC Healthcare (HKSE:02138) » Definitions » Beneish M-Score

EC Healthcare (HKSE:02138) Beneish M-Score : -2.54 (As of Jun. 23, 2024)


View and export this data going back to 2016. Start your Free Trial

What is EC Healthcare Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.54 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for EC Healthcare's Beneish M-Score or its related term are showing as below:

HKSE:02138' s Beneish M-Score Range Over the Past 10 Years
Min: -2.91   Med: -2.3   Max: -0.57
Current: -2.54

During the past 9 years, the highest Beneish M-Score of EC Healthcare was -0.57. The lowest was -2.91. And the median was -2.30.


EC Healthcare Beneish M-Score Historical Data

The historical data trend for EC Healthcare's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EC Healthcare Beneish M-Score Chart

EC Healthcare Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only -1.94 -2.91 -2.30 -2.91 -2.54

EC Healthcare Semi-Annual Data
Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - -2.91 - -2.54 -

Competitive Comparison of EC Healthcare's Beneish M-Score

For the Medical Care Facilities subindustry, EC Healthcare's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EC Healthcare's Beneish M-Score Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, EC Healthcare's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where EC Healthcare's Beneish M-Score falls into.



EC Healthcare Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of EC Healthcare for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.1813+0.528 * 1.0268+0.404 * 1.0252+0.892 * 1.3274+0.115 * 0.9852
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0111+4.679 * -0.097151-0.327 * 1.2464
=-2.54

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar23) TTM:Last Year (Mar22) TTM:
Total Receivables was HK$184 Mil.
Revenue was HK$3,875 Mil.
Gross Profit was HK$3,322 Mil.
Total Current Assets was HK$1,425 Mil.
Total Assets was HK$5,513 Mil.
Property, Plant and Equipment(Net PPE) was HK$1,587 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$587 Mil.
Selling, General, & Admin. Expense(SGA) was HK$405 Mil.
Total Current Liabilities was HK$1,676 Mil.
Long-Term Debt & Capital Lease Obligation was HK$1,132 Mil.
Net Income was HK$70 Mil.
Gross Profit was HK$0 Mil.
Cash Flow from Operations was HK$605 Mil.
Total Receivables was HK$117 Mil.
Revenue was HK$2,920 Mil.
Gross Profit was HK$2,570 Mil.
Total Current Assets was HK$1,516 Mil.
Total Assets was HK$4,861 Mil.
Property, Plant and Equipment(Net PPE) was HK$1,193 Mil.
Depreciation, Depletion and Amortization(DDA) was HK$432 Mil.
Selling, General, & Admin. Expense(SGA) was HK$302 Mil.
Total Current Liabilities was HK$1,363 Mil.
Long-Term Debt & Capital Lease Obligation was HK$622 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(183.617 / 3875.377) / (117.091 / 2919.5)
=0.04738 / 0.040107
=1.1813

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2569.897 / 2919.5) / (3322.424 / 3875.377)
=0.880252 / 0.857316
=1.0268

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (1424.612 + 1586.655) / 5513.33) / (1 - (1515.628 + 1193.316) / 4860.608)
=0.453821 / 0.442674
=1.0252

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=3875.377 / 2919.5
=1.3274

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(432.365 / (432.365 + 1193.316)) / (586.735 / (586.735 + 1586.655))
=0.265959 / 0.269963
=0.9852

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(405.362 / 3875.377) / (302.023 / 2919.5)
=0.104599 / 0.10345
=1.0111

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1131.881 + 1675.594) / 5513.33) / ((622.395 + 1363.431) / 4860.608)
=0.509216 / 0.408555
=1.2464

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(69.654 - 0 - 605.278) / 5513.33
=-0.097151

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

EC Healthcare has a M-score of -2.54 suggests that the company is unlikely to be a manipulator.


EC Healthcare Beneish M-Score Related Terms

Thank you for viewing the detailed overview of EC Healthcare's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


EC Healthcare (HKSE:02138) Business Description

Traded in Other Exchanges
Address
8 Argyle Street, L50, Langham Place Office Tower, Mong Kok, Hong Kong, HKG
EC Healthcare is a Hong Kong-based non-hospital medical service provider. The principal activities of the group include the provision of medical services; aesthetic medical services, comprising medical aesthetics and dental services; beauty and wellness services, comprising traditional beauty, haircare, and ancillary wellness services; and the sale of skincare, healthcare and beauty products. The group caters to its services through the operating segments of Medical which is the key revenue generator segment and Aesthetic medical, beauty and wellness, and Veterinary and others. Geographically, the group has a business presence in Hong Kong, Macau, and the PRC.
Executives
The Goldman Sachs Group, Inc. 2201 Interest of corporation controlled by you
Tang Chi Fai 2202 Interest of your spouse
Yau Ming Li 2101 Beneficial owner
Union Medical Care Holding Limited 2101 Beneficial owner

EC Healthcare (HKSE:02138) Headlines

No Headlines